Financials
- Market Capitalization 875.34 M
- Employee 174
- Founded 1996
- CEO N/A
- Website www.rigel.com
- Headquarter Delaware, United States
- FIGI BBG000BPWTW7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2497 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.79 USD | -0.55% | -1.01% | -6.17% | +31.75% | 944.10 M USD | ||
| 2539 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.04 USD | +0.06% | +0.41% | +0.95% | +18.75% | 884.70 M USD | ||
| 2565 | CLYM Climb Bio, Inc. - Common Stock | 15.06 USD | -6.34% | -12.75% | +21.26% | +175.32% | 864.99 M USD | ||
| 2579 | DBVT DBV Technologies S.A. - American Depositary Shares | 14.41 USD | -0.76% | -0.14% | +5.03% | +51.68% | 853.25 M USD |
Frequently asked questions about Rigel Pharmaceuticals Inc. (New)
What is the Rigel Pharmaceuticals Inc. (New) stock price today?
The current price of Rigel Pharmaceuticals Inc. (New) (RIGL) is 46.86. Over the past 24 hours, the stock has changed by +0.82%. Follow the RIGL chart for real-time price dynamics.
What is the stock ticker of Rigel Pharmaceuticals Inc. (New)?
Rigel Pharmaceuticals Inc. (New) trades under the ticker RIGL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rigel Pharmaceuticals Inc. (New) stock going up?
RIGL has changed by +2.45% over the last week, +21.46% over the last month, and +55.53% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Rigel Pharmaceuticals Inc. (New)?
Rigel Pharmaceuticals Inc. (New) currently has a market capitalization of 875.34 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Rigel Pharmaceuticals Inc. (New) earnings last quarter?
Last quarter, Rigel Pharmaceuticals Inc. (New) reported earnings of 0.93 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Rigel Pharmaceuticals Inc. (New) revenue for the last quarter?
Rigel Pharmaceuticals Inc. (New) reported quarterly revenue of 78.7 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Rigel Pharmaceuticals Inc. (New) net income for the last quarter?
Rigel Pharmaceuticals Inc. (New) reported net income of 17.29 M for the last quarter. The previous quarter showed 8.65 M, which means net income changed by +99.79%.
How many employees does Rigel Pharmaceuticals Inc. (New) have?
As of the latest available data, Rigel Pharmaceuticals Inc. (New) has 174 employees. Workforce size can provide additional context about the company's scale and operations.
What is Rigel Pharmaceuticals Inc. (New) EBITDA?
Rigel Pharmaceuticals Inc. (New) EBITDA is 24.42 M, and its EBITDA margin is 31.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Rigel Pharmaceuticals Inc. (New) stock?
You can buy Rigel Pharmaceuticals Inc. (New) (RIGL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rigel Pharmaceuticals Inc. (New) stock?
Investing in Rigel Pharmaceuticals Inc. (New) requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RIGL chart and related analysis on metatrader.com as part of your research.